Clinical Trials

Showing trials with last updates posted in 2025.

NCT06836414 | NOT_YET_RECRUITING | NA
1200 Participants

Lung Cancer Screening CT for Firefighters

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2026-03-31
Completion: 2035-12-31
Conditions
Smoke Inhalation Exposure, Inhalation Exposure to Pollution Exposure Occupational Lung Diseases Lung Cancer Lung Diseases, Interstitial Occupational Exposure Occupational Lung Disease Interstitial Lung Disease
Interventions
PROCEDURE OTHER
No Results Yet
NCT06833073 | RECRUITING | PHASE2
308 Participants

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-03-11
Completion: 2031-09-03
Conditions
Urinary Bladder Neoplasms Non-Muscle Invasive Bladder Neoplasms Carcinoma in Situ
Interventions
BIOLOGICAL
No Results Yet
NCT06831526 | RECRUITING | EARLY_PHASE1
12 Participants

Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-11-06
Completion: 2029-02-28
Conditions
Glioblastoma
Interventions
DRUG RADIATION PROCEDURE
No Results Yet
NCT06830629 | RECRUITING | PHASE2
56 Participants

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-02-05
Completion: 2026-09-30
Conditions
Proteinuric Kidney Disease
Interventions
DRUG
No Results Yet
NCT06830044 | RECRUITING | PHASE3
500 Participants

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-03-03
Completion: 2028-03-31
Conditions
Major Depressive Disorder (MDD)
Interventions
DRUG
No Results Yet
NCT06825871 | RECRUITING | NA
26 Participants

Automated Inhaler Monitoring for Asthma Medication Usage

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-12-31
Completion: 2026-03-31
Conditions
Asthma
Interventions
DEVICE
No Results Yet
NCT06822738 | RECRUITING | PHASE3
130 Participants

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-02-11
Completion: 2028-11-30
Conditions
Primary Open Angle Glaucoma
Interventions
DEVICE
No Results Yet
NCT06820957 | RECRUITING | PHASE2/PHASE3
437 Participants

Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2026-07-17
Completion: 2032-07-15
Conditions
CIC-Rearranged Sarcoma Metastatic Ewing Sarcoma Metastatic High Grade Sarcoma Metastatic Undifferentiated Round Cell Sarcoma Metastatic Undifferentiated Sarcoma, Not Otherwise Specified Round Cell Sarcoma With EWSR1-non-ETS Fusion Sarcoma With BCOR Genetic Alterations
Interventions
PROCEDURE DRUG OTHER RADIATION
No Results Yet
NCT06819891 | RECRUITING | PHASE3
425 Participants

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-05-12
Completion: 2028-12-31
Conditions
Moderately to Severely Active Crohns Disease
Interventions
DRUG
No Results Yet
NCT06819878 | RECRUITING | PHASE3
600 Participants

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-03-17
Completion: 2028-12-31
Conditions
Moderately to Severely Active Crohns Disease
Interventions
DRUG
No Results Yet
NCT06812494 | RECRUITING | PHASE2
200 Participants

A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-03-07
Completion: 2027-01-15
Conditions
HIV
Interventions
BIOLOGICAL
No Results Yet
NCT06811038 | NOT_YET_RECRUITING | PHASE3
854 Participants

iCanQuit Smoking Cessation Among Hispanic Adults

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2026-01-01
Completion: 2029-07-01
Conditions
Cigarette Smoking-Related Carcinoma
Interventions
DEVICE DRUG OTHER
No Results Yet
NCT06808477 | RECRUITING | PHASE1
198 Participants

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-02-27
Completion: 2026-08-21
Conditions
Atopic Dermatitis
Interventions
DRUG
No Results Yet
NCT06806592 | RECRUITING | PHASE3
400 Participants

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-09-13
Completion: 2027-07-17
Conditions
Interstitial Lung Diseases Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Interventions
DRUG
No Results Yet
NCT06805630 | RECRUITING | NA
50 Participants

Urine Methylation Markers in UTUC

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-05-07
Completion: 2026-06-30
Conditions
Upper Tract Urothelial Cancer
Interventions
DIAGNOSTIC_TEST
No Results Yet
NCT06804603 | COMPLETED | PHASE2
124 Participants

A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-02-25
Completion: 2025-10-06
Conditions
Obesity
Interventions
DRUG
No Results Yet
NCT06784752 | RECRUITING | PHASE3
240 Participants

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-05-30
Completion: 2030-09-27
Conditions
Somatostatin Receptor Positive (SSTR+) Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Interventions
RADIATION DRUG
No Results Yet
NCT06782490 | RECRUITING | PHASE2
200 Participants

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-06-05
Completion: 2026-11-18
Conditions
Multiple Sclerosis Spasticity
Interventions
DRUG
No Results Yet
NCT06780670 | RECRUITING | PHASE2/PHASE3
432 Participants

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-02-27
Completion: 2028-06-27
Conditions
Prostate Cancer
Interventions
DRUG
No Results Yet
NCT06780137 | RECRUITING | PHASE1/PHASE2
242 Participants

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-02-27
Completion: 2029-08-31
Conditions
Small Cell Lung Cancer
Interventions
BIOLOGICAL
No Results Yet
NCT06776783 | RECRUITING | PHASE3
520 Participants

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-09-24
Completion: 2027-05-31
Conditions
Respiratory Distress Syndrome Pre-term Infants
Interventions
COMBINATION_PRODUCT OTHER
No Results Yet
NCT06757647 | SUSPENDED | PHASE2
61 Participants

Acalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-05-27
Completion: 2026-12-31
Conditions
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Interventions
DRUG PROCEDURE
No Results Yet
NCT06755827 | NOT_YET_RECRUITING | PHASE1/PHASE2
30 Participants

Pilot Testing a Novel Approach to Pediatric Obesity Treatment

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-12-01
Completion: 2025-12-31
Conditions
Overweight Adolescents Obese Adolescents
Interventions
BEHAVIORAL OTHER
No Results Yet
NCT06751602 | ENROLLING_BY_INVITATION | PHASE2
40 Participants

Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-09-11
Completion: 2027-12-31
Conditions
Rejection Chronic Renal
Interventions
DRUG
No Results Yet
NCT06741072 | SUSPENDED | PHASE1
55 Participants

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-12-01
Completion: 2026-12-31
Conditions
Chronic Kidney Disease, Stage 4 Chronic Kidney Disease, Stage 5 EBV-Related Lymphoproliferative Disorder EBV-Related Malignant Neoplasm Post-Transplant Lymphoproliferative Disorder
Interventions
PROCEDURE DRUG BIOLOGICAL
No Results Yet
NCT06739668 | ACTIVE_NOT_RECRUITING | NA
30 Participants

Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive Dysfunction

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-12-19
Completion: 2025-12-31
Conditions
Post-Acute COVID-19 Syndrome Cognitive Dysfunction
Interventions
DEVICE
No Results Yet
NCT06735690 | RECRUITING | EARLY_PHASE1
15 Participants

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-06-09
Completion: 2029-03-07
Conditions
Acute Lymphoblastic Leukemia
Interventions
PROCEDURE BIOLOGICAL OTHER
No Results Yet
NCT06733935 | RECRUITING | PHASE1/PHASE2
144 Participants

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-11-04
Completion: 2028-10-31
Conditions
Systemic Sclerosis Idiopathic Inflammatory Myopathies Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Interventions
DRUG
No Results Yet
NCT06732440 | NOT_YET_RECRUITING | NA
48 Participants

Subthreshold Vestibular Stimulation as a Strategy for Rehabilitation

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2026-01-01
Completion: 2026-12-31
Conditions
Vestibular Hypofunction Bilateral Vestibular Hypofunction Presbyvestibulopathy Healthy Controls
Interventions
BEHAVIORAL OTHER
No Results Yet
NCT06732401 | RECRUITING | PHASE3
630 Participants

Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-08-07
Completion: 2028-06-30
Conditions
Lung Non-Small Cell Carcinoma Stage II Lung Cancer AJCC v8 Stage IIIA Lung Cancer AJCC v8 Stage IIIB Lung Cancer AJCC v8
Interventions
PROCEDURE DRUG BIOLOGICAL
No Results Yet
NCT06730347 | RECRUITING | PHASE2
60 Participants

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-05-01
Completion: 2027-02-28
Conditions
Platinum-resistant Ovarian Cancer Platinum-Resistant Fallopian Tube Carcinoma Platinum-Resistant Primary Peritoneal Carcinoma Clear Cell Adenocarcinoma of Ovary Clear Cell Adenocarcinoma of Vulva Clear Cell Adenocarcinoma of Vagina Clear Cell Adenocarcinoma of Cervix Clear Cell Adenocarcinoma of Uterus Clear Cell Adenocarcinoma of Fallopian Tube Clear Cell Adenocarcinoma of Peritoneum Endometrial Cancer
Interventions
BIOLOGICAL
No Results Yet
NCT06729398 | COMPLETED | NA
129 Participants

The Role of Cerebral NIRS in Preventing Brain Injury of Very Low Birth Weight Preterm Infants

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2017-05-01
Completion: 2020-05-01
Conditions
Neonatal Cerebral Leukomalacia Intracranial Nontraumatic Haemorrhage of Fetus and Newborn Neonatal Mortality
Interventions
DEVICE OTHER
No Results Yet
NCT06726148 | RECRUITING | PHASE1/PHASE2
280 Participants

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-04-03
Completion: 2028-09-25
Conditions
Advanced HR+/HER2- Breast Cancer Advanced CCNE1-amplified Solid Tumors
Interventions
DRUG
No Results Yet
NCT06717451 | ACTIVE_NOT_RECRUITING
144 Participants

PS230005 Control-IQ 1.5 Post-Approval Study

Study Type: OBSERVATIONAL
Last Updated: 2025-11-12
Start Date: 2025-01-30
Completion: 2026-08-11
Conditions
Type 1 Diabetes
Interventions
DEVICE
No Results Yet
NCT06717347 | RECRUITING | PHASE3
1046 Participants
NCT06697600 | RECRUITING | NA
640 Participants

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-07-11
Completion: 2029-10-01
Conditions
Oncology Myeloid Leukemia, Acute Cancer
Interventions
BEHAVIORAL
No Results Yet
NCT06697301 | RECRUITING | PHASE2/PHASE3
740 Participants

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-05-22
Completion: 2035-12-31
Conditions
Advanced Melanoma
Interventions
DRUG
No Results Yet
NCT06693310 | NOT_YET_RECRUITING | NA
200 Participants

STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-11-30
Completion: 2026-11-30
Conditions
Ulcerative Colitis (UC)
Interventions
OTHER
No Results Yet
NCT06692192 | RECRUITING | PHASE1
60 Participants

The RECAP2 Study: Midazolam and Psilocybin

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-08-07
Completion: 2027-12-31
Conditions
Psilocybin
Interventions
DRUG
No Results Yet
NCT06691113 | ACTIVE_NOT_RECRUITING | PHASE2
60 Participants

A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-12-16
Completion: 2026-08-07
Conditions
Chronic Rhinosinusitis Without Nasal Polyps
Interventions
DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page ยท Total 107726 trials